Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 23, 2025Journal of Cancer and Tumor InternationalOpen Access

Circulating Tumor DNA as a Biomarker in Colorectal Cancer: Diagnostic, Prognostic, and Therapeutic Perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

VNV NidhinshadGSGanthimathy SekharVVVipin Viswanath

Discussion

Loading...

Member takes

Overview

This review highlights the role of circulating tumor DNA in colorectal cancer diagnosis and prognosis, suggesting its use in non-invasive disease management.

Key Points

  • Circulating tumor DNA serves as a promising biomarker for colorectal cancer management.
  • Detection methods include digital PCR and multi-omics approaches to enhance precision.
  • Clinical applications range across diagnosis, prognosis, and monitoring therapy responses.
  • The integration of artificial intelligence may improve diagnostic capabilities for colorectal cancer.

Cite This Study

Nidhinshad et al. (2025) studied this question.

synapsesocial.com/papers/68fa32a40df2e6cd2f7422dahttps://doi.org/10.9734/jcti/2025/v15i4329
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fundamentals of ctDNA Biomarkers in Tumor Precision Medicine2025 · 1 citations
  2. 2Circulating tumor DNA in patients with cancer: insights from clinical laboratory2025
  3. 3Integrating Circulating Tumor DNA into Clinical Management of Colorectal Cancer: Practical Implications and Therapeutic Challenges2025 · 13 citations
  4. 4Circulating tumor cells and tumor-derived cell-free DNA in cancer management: Clinical evidence, limitations, and future directions2026
  5. 5Liquid clues: tracking early-stage breast cancer with ctDNA - a mini review2025 · 8 citations